Thoracic Outlet Syndrome (Investigational Adjunct)
Investigational adjunct for neurogenic thoracic outlet syndrome; postural correction and scalene rehabilitation remain first-line; surgical decompression for refractory or vascular subtypes.
Patient Summary
- Is this FDA-cleared for this use?
- Not FDA-cleared for thoracic outlet syndrome. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is investigational and is never appropriate for vascular TOS.
- What evidence exists?
- Tier C (investigational). No clinical study of leech therapy for thoracic outlet syndrome was identified, so its effect is unknown. Evidence-based first-line care for neurogenic TOS (95 percent of cases) is supervised physical therapy focused on postural correction, scalene and pectoralis stretching, brachial plexus mobilization, breathing-pattern retraining, and ergonomic modification - typically for 3 to 6 months. Refractory neurogenic cases or any vascular TOS (venous or arterial) require surgical evaluation for first-rib resection, scalenectomy, or vascular reconstruction. Subclavian vein thrombosis (Paget-Schroetter) is a vascular emergency requiring catheter-directed thrombolysis.
- Main risks
- Bleeding from the bite site for 6 to 24 hours after detachment
- Bruising over the upper trapezius for 5 to 10 days
- Local skin or, rarely, Aeromonas hydrophila infection
- Allergic reaction to leech saliva (uncommon)
- Worsening neurogenic symptoms from local irritation or tissue swelling near nerves
- CATASTROPHIC RISK if leech is misplaced into the supraclavicular fossa or anterior neck where the brachial plexus and subclavian vessels lie
- Delay of surgical evaluation in cases where TOS is vascular rather than neurogenic
- Who should not consider this
- Patients with ANY vascular TOS (venous or arterial) - this is a surgical emergency, not an investigational adjunct
- Patients with subclavian vein thrombosis (Paget-Schroetter syndrome)
- Patients with a confirmed cervical rib and vascular symptoms
- Patients with cervical radiculopathy mimicking TOS - imaging must distinguish first
- Patients who have not completed at least 12 weeks of supervised physical therapy
- Patients on anticoagulants, with hemophilia, or with anemia
- Patients with active dermatitis or broken skin over the upper trapezius
- What to ask your clinician
- Has imaging (duplex ultrasound, CTA, or MRA) ruled out vascular TOS?
- Have I been worked up for cervical radiculopathy, brachial plexopathy, or carpal/cubital tunnel as alternative or additional diagnoses?
- Have I completed a structured 3 to 6 month physical therapy program with a thoracic-outlet-experienced therapist?
- Am I a candidate for surgical decompression (first-rib resection, scalenectomy)?
- Where exactly will leeches be placed - confirm strictly over upper trapezius, NEVER in the supraclavicular fossa or anterior neck?
- What is the practitioner's experience with TOS specifically, and stopping rules if symptoms worsen?
- What is the Aeromonas-prevention protocol?
- When to seek urgent care
- Sudden arm swelling, blueness, or coolness (possible subclavian vein thrombosis - vascular emergency)
- Sudden severe arm pain with pallor or pulselessness (possible arterial occlusion - 911)
- Sudden severe weakness, sensory loss, or inability to grip with the arm (possible brachial plexus injury)
- Calf swelling, redness, or warmth (possible DVT from immobility)
- Bleeding from the bite site lasting more than 24 hours
- Fever, chills, or spreading redness at the bite site
- Hives, facial or throat swelling, or breathing difficulty
What this does NOT mean
- This is not FDA-cleared for thoracic outlet syndrome.
- It is NEVER appropriate for vascular TOS, which is a surgical condition; delay can risk limb loss or pulmonary embolism.
- It does not replace supervised physical therapy, which is the strongest neurogenic TOS evidence intervention.
- It is not applied to the supraclavicular fossa or anterior neck, where the brachial plexus and subclavian vessels lie.
- No clinical study or case report of leech therapy for thoracic outlet syndrome was identified; its benefit is unproven.
Safety cross-references
Clinical Profile
- Category
- Neurological
- ICD-10
- G54.0, I87.1
- Safety tier
- High
Evidence Summary
Thoracic outlet syndrome (TOS) compresses the brachial plexus and/or subclavian vessels in the thoracic outlet. Neurogenic TOS (95 percent of cases) is managed with postural correction, scalene and pectoralis stretching, breathing-pattern retraining, and ergonomic modification under supervised physical therapy; refractory cases may require first-rib resection or scalenectomy. Vascular TOS (venous or arterial) is a surgical condition. No clinical study or case report of hirudotherapy for thoracic outlet syndrome was identified in PubMed, Europe PMC, Crossref or Russian- and German-language sources as of October 2026; any rationale is mechanistic only. The supraclavicular fossa contains the brachial plexus and subclavian artery and vein — direct placement there is absolutely contraindicated.
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)
Contraindications
- Hemophilia or another bleeding disorder
- Taking anticoagulants (blood thinners such as warfarin or heparin)
- Anemia or suppressed blood formation
- Low blood pressure, shock, collapse or fainting
- Severe wasting (cachexia)
- Intolerance of leeches or a history of severe allergic reactions
- Pregnancy
- Stomach or duodenal ulcer, erosive gastritis
- Acute infectious disease or high fever
- Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
- Drinking alcohol at the time of treatment
- No consent from the patient
- Active deep vein thrombosis (acute phase)
- Critical limb ischemia (ABI <0.4)
- Vascular (venous or arterial) TOS — surgical condition
- Supraclavicular or anterior neck placement (brachial plexus, subclavian vessels)
- Subclavian vein thrombosis (Paget-Schroetter)
- Cervical rib confirmed with vascular symptoms
- Cervical radiculopathy mimicking TOS
Related Conditions
Cervical Radiculopathy
Investigational use for cervical radiculopathy; no verifiable published trial specific to this indication.
Carpal Tunnel Syndrome (Mild-Moderate)
Investigational use for mild-to-moderate carpal tunnel syndrome; only one single-patient case report and one randomized-trial protocol without results were identified.
Chronic Cervical Myofascial Pain (Investigational Adjunct)
Investigational adjunct for chronic cervical myofascial pain; education, exercise therapy, ergonomic correction, and trigger-point therapy remain primary.
Lumbar Radiculopathy (Sciatica)
Investigational use for lumbar radiculopathy; the closest randomized evidence is in chronic low back pain (Hohmann 2018, n=44), not radicular pain.